Connecting Research and Experts with Journalists

• share
• favorite_border

Na Mayo Clinic, a missão de resolver o que está sem solução está no cerne de todos os casos de doenças raras. Cada diagnóstico é uma prova de perseverança, de inovação e da busca incessante por respostas. Este compromisso levou os pesquisadores do Centro de Medicina Personalizada da Mayo Clinic a desenvolver um sistema semiautomático, conhecido como RENEW, para reanalisar rapidamente casos de doenças raras não solucionadas.

• share
• favorite_border

A machine learning tool developed by Cedars-Sinai investigators can answer questions about genes, drugs, and biochemical pathways associated with Alzheimer’s disease and other health conditions. Their findings were published today in the journal Bioinformatics.

• share
• favorite_border

A cutting-edge study harnesses the power of spaceborne Global Navigation Satellite System-Reflectometry (GNSS-R) technology to accurately measure sea ice thickness, a critical parameter for understanding climate change impacts in polar regions.

• share
• favorite_border

Researchers have achieved a breakthrough in thermal management with the development of metamaterials that can control both heat and electrical currents simultaneously. These innovative materials offer precise manipulation of thermoelectric fields, enabling functions like focusing and redirecting thermal energy and electrical power. This dual functionality addresses limitations in traditional metamaterials, paving the way for advanced applications in thermal management.

• share
• favorite_border

A comprehensive review from The Second Xiangya Hospital of Central South University outlines how deep learning is transforming the diagnosis, treatment, and prognosis of soft tissue sarcomas, offering new hope for patients.

• share
• favorite_border

Teens and young adults who experience social problems related to alcohol may be at risk of relatively rapid development of alcohol use disorder (AUD), a new study suggests. Other behaviors that meet certain diagnostic criteria may also warn of the potential for an accelerated transition from a first drink to the disorder.

• share
• favorite_border

New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.

• share
• favorite_border

The safety and efficiency of a large, complex nuclear reactor can be enhanced by hardware as simple as a tiny sensor that monitors a cooling system. That’s why researchers at the Department of Energy’s Oak Ridge National Laboratory are working to make those basic sensors more accurate by pairing them with electronics that can withstand the intense radiation inside a reactor.

• share
• favorite_border

A weekly dose of semaglutide 2.4 mg significantly reduced the risk of major adverse cardiovascular events (MACEs) in people with overweight or obesity and cardiovascular disease but not diabetes, regardless of blood sugar level, according to a clinical trial including researchers from UT Southwestern Medical Center. The findings, published in Diabetes Care, also show the reduction in MACEs – a combination of heart attacks, stroke, or death from cardiovascular causes – isn’t due to the drug’s effect in lowering blood sugar.